SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

19 May 2025 Evaluate
The revenue for the March 2025 quarter is pegged at Rs. 122.91 millions, about 6.42% up against Rs. 115.50 millions recorded during the year-ago period.Profit after tax for the quarter ended March 2025 reported a huge growth of 70.16% to Rs. 11.86  millions from Rs. 6.97 millions.Operating profit for the quarter ended March 2025 decreased to 52.92 millions as compared to 53.38 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 122.91 115.50 6.42 466.72 448.81 3.99 466.72 448.81 3.99
Other Income 1.53 0.09 1600.00 48.05 0.39 12220.51 48.05 0.39 12220.51
PBIDT 52.92 53.38 -0.86 256.01 211.23 21.20 256.01 211.23 21.20
Interest 16.81 15.18 10.74 75.04 77.78 -3.52 75.04 77.78 -3.52
PBDT 36.11 38.20 -5.47 180.97 133.45 35.61 180.97 133.45 35.61
Depreciation 22.46 24.26 -7.42 90.17 92.91 -2.95 90.17 92.91 -2.95
PBT 13.65 13.94 -2.08 90.80 40.54 123.98 90.80 40.54 123.98
TAX 1.79 6.97 -74.32 15.11 15.32 -1.37 15.11 15.32 -1.37
Deferred Tax -3.10 -0.32 868.75 -5.72 -1.43 300.00 -5.72 -1.43 300.00
PAT 11.86 6.97 70.16 75.69 25.22 200.12 75.69 25.22 200.12
Equity 171.65 149.04 15.17 171.65 149.04 15.17 171.65 149.04 15.17
PBIDTM(%) 43.06 46.22 -6.84 54.85 47.06 16.55 54.85 47.06 16.55

Vivo Bio Tech Share Price

28.92 0.60 (2.12%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×